heart-rate-pulse-graph

Mucopolysaccharidosis Type II (Hunter Syndrome, MPS II)

Anesthesia Implications

Clinically reviewed by anesthesia providers · Updated

Risk factors

  • Difficult Airway
  • Video Laryngoscope
  • C-spine
  • Careful Positioning
  • Copious Secretions
  • Reactive Airway
  • Bronchospasm risk
  • Aspiration
  • Increased ICP
  • Arrhythmias
  • Pulmonary Hypertension
  • Avoid Hypoxia
  • Avoid Opioids
  • Reduced Cardiac Output
  • Obstructive Sleep Apnea
  • Restrictive Lung Disease
  • Valvular Heart Disease

Pathophysiology

Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is an X-linked recessive lysosomal storage disease caused by deficient iduronate 2-sulfatase, the first enzyme in the breakdown of heparan and...

Continue reading

Read the full condition post with a free account

Free. It opens 5 posts in each part of the library: drugs, surgeries and conditions.

Already have an account?

Prefer the app? Get Master Anesthesia on iOS or Android.